Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes With Clinicopathologic Characteristics and Prognosis in Young Women With HR+/HER2- BC"

0 views
June 7, 2023
Comments 0
Login to view comments. Click here to Login